METHODS	Adult outpatients with DSM-IV-defined MDD were randomly assigned to desvenlafaxine 100 mg/day ( N = 114 ) , 200 mg/day ( N = 116 ) , or 400 mg/day ( N = 113 ) or placebo ( N = 118 ) for 8 weeks .\